OTC Markets EXMKT - Delayed Quote USD

Manhattan Scientifics, Inc. (MHTX)

0.0001
0.0000
(0.00%)
At close: May 23 at 11:57:39 AM EDT
Loading Chart for MHTX
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0005 x --
  • Ask 0.0007 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0019
  • Volume 369,250
  • Avg. Volume 73,899
  • Market Cap (intraday) 55,928
  • Beta (5Y Monthly) 1.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Jun 5, 2025 - Jun 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

mhtx.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MHTX

View More

Performance Overview: MHTX

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MHTX
83.33%
S&P 500 (^GSPC)
1.34%

1-Year Return

MHTX
93.75%
S&P 500 (^GSPC)
10.16%

3-Year Return

MHTX
99.22%
S&P 500 (^GSPC)
46.03%

5-Year Return

MHTX
99.13%
S&P 500 (^GSPC)
96.34%

Compare To: MHTX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MHTX

View More

Valuation Measures

Annual
As of 5/22/2025
  • Market Cap

    55.93k

  • Enterprise Value

    77.93k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -132.78%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.06M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    146.12k

Research Analysis: MHTX

View More

Company Insights: MHTX

Research Reports: MHTX

View More

People Also Watch